Authored by Novus Insights
16/09/2026
A robot assisting a surgeon, an algorithm reading a brain scan, and a wearable sharing patient data may seem unrelated, but they are increasingly part of the same healthcare transformation. Robotics is extending physical capabilities, AI is supporting faster and more informed decisions, and connectivity is linking patients, devices, and care teams across settings. Together, these technologies are influencing surgery, diagnosis, rehabilitation, hospital operations, and care at home. Yet adoption still depends on factors such as cost, integration, safety, regulation, trust, and measurable value. This article explores how robotics, AI, and connectivity are reshaping healthcare and how healthcare market research can help businesses and other stakeholders assess emerging opportunities.
Robotic-assisted surgery remains one of the most visible applications of healthcare robotics. Systems such as Intuitive Surgical's da Vinci, Stryker's Mako, and CMR Surgical's Versius demonstrate how robotics can support complex procedures while maintaining clinician control.
The category continues to evolve. Stryker, for example, commercially launched its Mako RPS handheld robotic system for total knee replacement in the US in July 2026, expanding its Mako portfolio beyond robotic-arm-assisted surgery. Versius has also expanded internationally, with CMR Surgical reporting in March 2026 that more than 45,000 patients worldwide had been treated using the system.
But the next generation of healthcare robotics extends much further than surgery.
Robotic and wearable systems are being explored across:
The opportunity is not limited to highly autonomous humanoid robots. In many cases, commercially viable systems may be those designed to solve one narrow, costly, or labor-intensive healthcare problem reliably.
Read Also: WHY HEALTHCARE MARKET RESEARCH MUST EVOLVE FOR A POST-AI, POST-PANDEMIC WORLD
While robotics can extend physical capabilities, AI is increasingly being applied to information-intensive decisions.
Imaging represents one of the clearest examples. AI tools are being researched and deployed to help analyze radiology, pathology, ophthalmology, and other clinical images, potentially helping clinicians recognize abnormalities, prioritize cases, or quantify findings.
One Imperial College London study found an AI model was twice as accurate as standard visual assessment in estimating stroke timing from brain scans.
Such tools are generally more relevant as clinical decision support than as straightforward replacements for clinicians. Their value depends on whether they can fit safely into existing pathways and produce information clinicians can confidently act upon.
Machine learning can identify patterns across clinical, genomic, imaging, and behavioral data to support risk prediction and earlier intervention. Life science market research can help assess clinician acceptance, priority use cases, and evidence requirements.
AI also has potential beyond diagnosis.
A National Institute for Health and Care Research (NIHR)-reviewed study used more than 100,000 linked ambulance and emergency-care records from Yorkshire to develop a model predicting whether patients needed to attend an emergency department. The model correctly predicted potentially avoidable emergency department attendance about eight times out of ten.
Similar approaches can support predictions around hospital admissions, bed requirements, patient deterioration, and demand on clinical services. For capacity-constrained healthcare systems, these operational applications may prove as important as more visible diagnostic tools.
AI assistants are also entering patient and clinician workflows through applications such as:
The level of risk varies significantly by use case. An AI tool answering scheduling questions has very different clinical implications from one influencing diagnosis or treatment. Developers therefore need to understand not only whether users want an AI feature, but how much responsibility they are willing to delegate to it.
Robotics and AI become considerably more powerful when healthcare data can move securely between devices, systems, professionals, and locations.
Connected medical devices, wearables, remote patient monitoring platforms, smart hospital equipment, and home-monitoring technologies are expanding the amount of data available beyond a traditional clinical encounter.
For example, a connected rehabilitation device could capture how a patient is moving, transmit performance data, use algorithms to identify patterns, and allow a therapist to review progress remotely. Similarly, a wearable could continuously collect physiological information and flag concerning changes for further assessment.
This shift turns connectivity from a technical feature into part of the care model itself.
It also creates new commercial questions. Healthcare providers must consider interoperability with electronic health records, network reliability, cybersecurity, data governance, device management, and whether additional information actually improves clinical decisions.
The more significant transformation may come not from any one of these technologies but from their convergence.
Consider robotic-assisted surgery. A robotic platform can guide or execute specific physical movements, imaging and sensors can generate procedural data, and AI can potentially support planning or analysis. Connected operating-room infrastructure can then link information across systems.
The same pattern can emerge in rehabilitation: sensors capture movement, connected systems transmit the information, AI interprets performance, and a robotic or wearable device adjusts the physical assistance provided.
In remote care, a connected device collects patient information, AI identifies a possible risk, and a healthcare professional determines whether intervention is necessary.
The transformation can therefore be viewed as a continuous cycle:
Connected data → intelligent analysis → informed clinical or physical action.
This convergence is also likely to create opportunities for partnerships between medtech manufacturers, software businesses, pharmaceutical companies, healthcare providers, and technology firms.
Read Also: HOW HEALTHCARE MARKET RESEARCH CONSULTANTS HELP BUSINESSES NAVIGATE MARKET UNCERTAINTY
Several healthcare pressures, such as an aging population and demand for productivity, are helping move these technologies from experimentation toward practical applications. Meanwhile, advances in computer vision, sensors, machine learning, computing power, and robotics are broadening what can technically be achieved. A successful demonstration or clinical study, however, is only one part of bringing an emerging healthcare technology to market.
Organizations still need to address several barriers:
These uncertainties mean organizations cannot evaluate market readiness from technical performance alone.
A technology may perform well in development or clinical testing, but that does not automatically mean the market is ready to adopt it. Healthcare market research consultants can help companies evaluate demand, stakeholder expectations, commercial viability, and the practical barriers that may influence uptake.
Before entering a market, healthcare innovators should be able to answer several fundamental questions:
Answering these questions early can help companies distinguish technological excitement from sustainable opportunity. This is where healthcare market research becomes especially valuable.
Robotics, AI, and connectivity are reshaping healthcare, but successful adoption depends on solving real needs and delivering measurable value. Novus Insights supports healthcare, pharmaceutical, and life sciences companies with tailored research across market opportunity, go-to-market strategy, competitive intelligence, and stakeholder insights. Our global research capabilities combine deep domain expertise, reliable data, and technology-driven methodologies, including access to hard-to-reach B2B decision-makers. We also offer KWIK, an AI-powered DIY research tool, for those requiring faster, more agile research.
Connect with Novus Insights to turn healthcare innovation into informed, evidence-backed business decisions. Call us at +91 124-436-6686, +91 7428 225 350, or via email at contactus@novusinsights.com. You may also fill out our contact form, and our representatives will reach out to you at the earliest.
Q.1. How can healthcare market research help robotics companies assess market potential?
It can identify unmet clinical needs, target customers, competing solutions, purchasing criteria, pricing expectations, and barriers that may influence the adoption of robotic systems.
Q.2. What research should a healthcare AI company conduct before entering a new market?
Useful research may include market sizing, stakeholder interviews, workflow analysis, competitor assessment, regulatory research, pricing studies, and evaluation of clinician and patient attitudes toward AI.
Q.3. How can companies measure clinician willingness to adopt AI or robotic technologies?
Qualitative interviews, surveys, concept testing, and conjoint or trade-off studies can reveal which benefits, features, evidence, and workflow considerations have the greatest influence on adoption.
Q.4. What factors influence hospital purchasing decisions for healthcare robotics?
Hospitals may consider clinical outcomes, capital cost, utilization, training requirements, maintenance, infrastructure, integration, reimbursement, patient volumes, and expected return on investment.
Q.5. How can pharmaceutical market research support connected-health strategies?
It can assess patient and physician needs, digital engagement preferences, treatment pathways, partnership opportunities, and the potential role of connected technologies alongside pharmaceutical therapies.
Q.6. How can market research help determine the right pricing model for healthcare technology?
Research can test willingness to pay and compare models such as upfront capital purchases, subscriptions, pay-per-use arrangements, leasing, or service-based offerings.
Q.7. What should companies evaluate before commercializing connected medical technology internationally?
They should consider local healthcare infrastructure, clinical practices, regulation, reimbursement, connectivity, data-protection requirements, competitive conditions, pricing expectations, and stakeholder readiness.